Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Neurotox Res ; 32(4): 614-623, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28695546

RESUMEN

The Na+/myo-inositol cotransporter (SMIT1) is overexpressed in human Down syndrome (DS) and in trisomy 16 fetal mice (Ts16), an animal model of the human condition. SMIT1 overexpression determines increased levels of intracellular myo-inositol, a precursor of phophoinositide synthesis. SMIT1 is overexpressed in CTb cells, an immortalized cell line established from the cerebral cortex of a Ts16 mouse fetus. CTb cells exhibit impaired cytosolic Ca2+ signals in response to glutamatergic and cholinergic stimuli (increased amplitude and delayed time-dependent kinetics in the decay post-stimulation), compared to our CNh cell line, derived from the cerebral cortex of a euploid animal. Considering the role of myo-inositol in intracellular signaling, we normalized SMIT1 expression in CTb cells using specific mRNA antisenses. Forty-eight hours post-transfection, SMIT1 levels in CTb cells reached values comparable to those of CNh cells. At this time, decay kinetics of Ca2+ signals induced by either glutamate, nicotine, or muscarine were accelerated in transfected CTb cells, to values similar to those of CNh cells. The amplitude of glutamate-induced cytosolic Ca2+ signals in CTb cells was also normalized. The results suggest that SMIT1 overexpression contributes to abnormal cholinergic and glutamatergic Ca2+ signals in the trisomic condition, and knockdown of DS-related genes in our Ts16-derived cell line could constitute a relevant tool to study DS-related neuronal dysfunction.


Asunto(s)
Corteza Cerebral/metabolismo , Colinérgicos/farmacología , Ácido Glutámico/metabolismo , Simportadores/metabolismo , Acetilcolina/metabolismo , Animales , Línea Celular , Supervivencia Celular , Corteza Cerebral/efectos de los fármacos , Cromosomas Humanos Par 16/genética , Cromosomas Humanos Par 16/metabolismo , Modelos Animales de Enfermedad , Síndrome de Down/genética , Feto/efectos de los fármacos , Ratones , Mosaicismo , Neuronas/efectos de los fármacos , Nicotina/farmacología , Simportadores/genética , Trisomía/genética
2.
Exp Neurol ; 209(1): 234-42, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17976585

RESUMEN

Murine trisomy 16 (Ts16) is a useful model to study the deleterious effect of aneuploidy in neural pathophysiology. The CTb cell line derived from the cerebral cortex of a Ts16 mouse overexpresses the amyloid precursor protein (APP) and exhibits altered intracellular Ca(2+) homeostasis. In the present work, we induced knockdown of APP by transfecting specific mRNA antisense sequences into CTb cells. Forty-eight hours after transfection, the APP expression was knocked down by 40%, reaching levels comparable to those of the cortical line CNh, derived from a normal animal. Calcium measurements showed that the APP knockdown decreased intracellular Ca(2+) basal levels and accelerated the kinetics of the decay of Ca(2+) responses induced by glutamatergic agonists, nicotine, depolarization or ionomycin, to levels similar to those previously reported for CNh cells. The present results suggest that APP overexpression plays an important role on the altered intracellular Ca(2+) homeostasis in the trisomic cells.


Asunto(s)
Precursor de Proteína beta-Amiloide/genética , Calcio/metabolismo , Corteza Cerebral/metabolismo , Neuronas/fisiología , Trisomía/genética , Animales , Western Blotting , Línea Celular , Corteza Cerebral/citología , Agonistas de Aminoácidos Excitadores/farmacología , Ionomicina/farmacología , Ionóforos/farmacología , Cinética , Ratones , Ratones Transgénicos , Nicotina/farmacología , Agonistas Nicotínicos/farmacología , ARN sin Sentido/genética , Receptores de Glutamato/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...